Live Breaking News & Updates on Genfit company profile

Stay updated with breaking news from Genfit company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genfit (EPA:GNFT) Trading Down 0.8%

Shares of Genfit S.A. (EPA:GNFT – Get Free Report) fell 0.8% on Thursday . The company traded as low as €3.19 ($3.39) and last traded at €3.21 ($3.41). 36,724 shares were traded during mid-day trading, The stock had previously closed at €3.24 ($3.44). Genfit Price Performance The business’s fifty day moving average is €3.26 and […]

Genfit-company-profile , Get-free-report , Urea-cycle-disorder , Organic-acidemia-disorder , Blood-ammonia , Genfit-daily , Genfit , Epa-gnft , Gnft , Medical , Stocks

Genfit (EPA:GNFT) Trading Up 1.1%

Genfit (EPA:GNFT) Trading Up 1.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Genfit-company-profile , Get-free-report , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily ,

Genfit (EPA:GNFT) Stock Price Up 1.1%

Genfit (EPA:GNFT) Stock Price Up 1.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Genfit-company-profile , Get-free-report , Stock-down , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily ,

Leerink Partnrs Comments on Genfit S.A.'s FY2026 Earnings (NASDAQ:GNFT)

Genfit S.A. (NASDAQ:GNFT – Free Report) – Research analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Genfit in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per share of ($0.67) for the year. The consensus estimate for Genfit’s current […]

Leerink-partnrs , Shaughnessy-asset-management , Citadel-advisors , Envestnet-asset-management-inc , Optiver-holding , Genfit-company-profile , Free-report , Asset-management , Get-free-report , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily

Short Interest in Genfit S.A. (OTCMKTS:GNFTF) Grows By 91.2%

Genfit S.A. (OTCMKTS:GNFTF – Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 115,300 shares, an increase of 91.2% from the November 30th total of 60,300 shares. Based on an average daily trading volume, of 300 shares, the days-to-cover ratio […]

Genfit-company-profile , Get-free-report , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily , Genfit , Otcmkts-gnftf , Gnftf , Medical , Stocks , Options

Genfit (NASDAQ:GNFT) Rating Reiterated by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. Genfit Price Performance GNFT stock opened at $3.43 on Friday. Genfit has a 1-year low of $2.89 and a 1-year […]

Genfit-company-profile , Citadel-advisors , Envestnet-asset-management-inc , Shaughnessy-asset-management , O-shaughnessy-asset-management , Optiver-holding , Free-report , Asset-management , Get-free-report , Urea-cycle-disorder , Organic-acidemia-disorder

Genfit S.A. (NASDAQ:GNFT) Sees Large Decrease in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 114,300 shares, a drop of 8.1% from the September 15th total of 124,400 shares. Based on an average daily volume of 26,800 shares, the […]

Shaughnessy-asset-management , Citadel-advisors , Genfit-company-profile , Optiver-holding , Envestnet-asset-management-inc , Nasdaq , Get-free-report , Asset-management , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily

Equities Analysts Offer Predictions for Genfit S.A.'s FY2024 Earnings (NASDAQ:GNFT)

Equities Analysts Offer Predictions for Genfit S.A.'s FY2024 Earnings (NASDAQ:GNFT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs , Genfit-company-profile , Optiver-holding , Envestnet-asset-management-inc , Citadel-advisors , Shaughnessy-asset-management , Free-report , Asset-management , Get-free-report , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily

Genfit S.A. (NASDAQ:GNFT) Sees Large Drop in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 104,000 shares, a decrease of 10.2% from the August 15th total of 115,800 shares. Currently, 0.2% of the shares of the company are short […]

Shaughnessy-asset-management , Optiver-holding , Genfit-company-profile , Citadel-advisors , Envestnet-asset-management-inc , Get-free-report , Asset-management , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily , Genfit

Genfit (GNFTF) versus Its Competitors Head-To-Head Comparison

Genfit (OTCMKTS:GNFTF – Free Report) is one of 374 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Genfit to related businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, earnings, dividends and profitability. Valuation & Earnings This table compares Genfit and its […]

France , Genoscience-pharma , Genfit-company-profile , Free-report , Given-genfit , Urea-cycle-disorder , Organic-acidemia-disorder , Genfit-daily , Genfit , Otcmkts-gnftf , Gnftf , Medical